188 related articles for article (PubMed ID: 31438847)
1. Prediction of regulatory targets of alternative isoforms of the epidermal growth factor receptor in a glioblastoma cell line.
Weinholdt C; Wichmann H; Kotrba J; Ardell DH; Kappler M; Eckert AW; Vordermark D; Grosse I
BMC Bioinformatics; 2019 Aug; 20(1):434. PubMed ID: 31438847
[TBL] [Abstract][Full Text] [Related]
2. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.
He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A
Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832
[TBL] [Abstract][Full Text] [Related]
3. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
4. Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling.
Azad AK; Lawen A; Keith JM
BMC Syst Biol; 2015 Jan; 9():2. PubMed ID: 25599599
[TBL] [Abstract][Full Text] [Related]
5. EGFR isoforms and gene regulation in human endometrial cancer cells.
Albitar L; Pickett G; Morgan M; Wilken JA; Maihle NJ; Leslie KK
Mol Cancer; 2010 Jun; 9():166. PubMed ID: 20579378
[TBL] [Abstract][Full Text] [Related]
6. Characterization and expression of novel 60-kDa and 110-kDa EGFR isoforms in human placenta.
Reiter J; Maihle NJ
Ann N Y Acad Sci; 2003 May; 995():39-47. PubMed ID: 12814937
[TBL] [Abstract][Full Text] [Related]
7. A new class of protein cancer biomarker candidates: differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell lines.
Omenn GS; Guan Y; Menon R
J Proteomics; 2014 Jul; 107():103-12. PubMed ID: 24802673
[TBL] [Abstract][Full Text] [Related]
8. EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression.
Bhinge K; Yang L; Terra S; Nasir A; Muppa P; Aubry MC; Yi J; Janaki N; Kovtun IV; Murphy SJ; Halling G; Rahi H; Mansfield A; de Andrade M; Yang P; Vasmatzis G; Peikert T; Kosari F
Oncotarget; 2017 Apr; 8(16):27155-27165. PubMed ID: 28460442
[TBL] [Abstract][Full Text] [Related]
9. Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A.
Wang W; Zhang H; Liu S; Kim CK; Xu Y; Hurley LA; Nishikawa R; Nagane M; Hu B; Stegh AH; Cheng SY; Cheng C
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8366-8371. PubMed ID: 28716909
[TBL] [Abstract][Full Text] [Related]
10. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.
Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907
[TBL] [Abstract][Full Text] [Related]
11. The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme.
Canute GW; Longo SL; Longo JA; Shetler MM; Coyle TE; Winfield JA; Hahn PJ
Neurosurgery; 1998 Mar; 42(3):609-16. PubMed ID: 9526995
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
[TBL] [Abstract][Full Text] [Related]
13. High level EGFR amplification in a newly established glioblastoma cell line 170-MG-BA.
MacLeod RAF; Schneider B; Sivakova I; Nagel S; Dirks WG; Mraz P; Kubikova E; Perzelova A
Neoplasma; 2019 Jan; 66(1):109-117. PubMed ID: 30509096
[TBL] [Abstract][Full Text] [Related]
14. Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing.
Gupta S; Zink D; Korn B; Vingron M; Haas SA
BMC Genomics; 2004 Sep; 5():72. PubMed ID: 15453915
[TBL] [Abstract][Full Text] [Related]
15. EGFR soluble isoforms and their transcripts are expressed in meningiomas.
Guillaudeau A; Durand K; Bessette B; Chaunavel A; Pommepuy I; Projetti F; Robert S; Caire F; Rabinovitch-Chable H; Labrousse F
PLoS One; 2012; 7(5):e37204. PubMed ID: 22623992
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo.
Saydam O; Glauser DL; Heid I; Turkeri G; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
Mol Ther; 2005 Nov; 12(5):803-12. PubMed ID: 16112910
[TBL] [Abstract][Full Text] [Related]
17. EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer.
Babic I; Anderson ES; Tanaka K; Guo D; Masui K; Li B; Zhu S; Gu Y; Villa GR; Akhavan D; Nathanson D; Gini B; Mareninov S; Li R; Camacho CE; Kurdistani SK; Eskin A; Nelson SF; Yong WH; Cavenee WK; Cloughesy TF; Christofk HR; Black DL; Mischel PS
Cell Metab; 2013 Jun; 17(6):1000-1008. PubMed ID: 23707073
[TBL] [Abstract][Full Text] [Related]
18. Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma.
Michiue H; Eguchi A; Scadeng M; Dowdy SF
Cancer Biol Ther; 2009 Dec; 8(23):2306-13. PubMed ID: 19901546
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic implication of alterations in epidermal growth factor receptor and MGMT in glioblastoma].
Zhang LY; Ge HJ; Wang LM; Zhao LH; Liu L; Zhang DJ; Cai YN; Lu DH; Piao YS
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):186-191. PubMed ID: 30831643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
